IMTM HTS facility was a part of a special event - a celebration of the ISIDORe project achievements. The conference showcased various projects and innovations that have advanced research on pandemic preparedness and response. We presented results of HTS screening campaign focused on discovery of novel inhibitors of coronavirus infections done in collaboration with professor Michael Bader from MDC, Berlin and supported by EU-Openscreen project manager Charlotte Wit.
As the ISIDORe project concluded its groundbreaking journey, we came together to celebrate its achievements at the second ISIDORe Users’ Conference, held in Paris and online on June 11–12, 2025. The event showcased the diverse research supported by ISIDORe’s infrastructure services and its significant contributions to pandemic preparedness.
It was a valuable opportunity to share scientific results, reconnect with the ISIDORe community, and reflect on our shared efforts to advance infectious disease research. Thank you to everyone who participated and helped shape this inspiring conclusion.
Read more about ISIDORe research project.
